Children diagnosed with attention-deficit/hyperactivity disorder who also present with comorbid anxiety exhibit significant reductions in electrophysiological alpha peak frequency compared to children diagnosed with attention-deficit/hyperactivity disorder alone, according to an observational neurobehavioral study. Electrophysiological testing across brain sites indicated an overall reduction in this marker among the comorbid cohort, with multiplicity-adjusted post hoc comparisons confirming statistically significant decreases at central and occipital electrode placements.
The research investigation evaluated alpha peak frequency alongside two established electrophysiological indices, namely the theta/beta ratio and the sensorimotor rhythm. By recording electroencephalographic signals across frontal, central, and occipital scalp regions, the investigators sought to determine whether these neurophysiological measures could effectively differentiate children diagnosed with attention-deficit/hyperactivity disorder alone from those managing both the disorder and co-occurring anxiety conditions.
The study cohort comprised 98 pediatric participants between the ages of 8 and 16 years, reflecting an overall sample mean age of 10.1 years with a standard deviation of 2.25 years. Every participating child met formal diagnostic criteria for attention-deficit/hyperactivity disorder as outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. For analytical comparisons, the investigators allocated the children into two clinical groups: an attention-deficit/hyperactivity disorder group consisting of 46 individuals and a comorbid group encompassing 52 individuals.
Behavioral profiles for all participants were evaluated through standardized parent-report instruments, utilizing the Conners’ Parent Rating Scale-Revised alongside the Spence Children’s Anxiety Scale. Behavioral outcomes demonstrated that children in the comorbid cohort scored significantly higher on the Spence anxiety measures than their peers in the attention-deficit/hyperactivity disorder alone group. In contrast, parental ratings assessing core attention-deficit/hyperactivity disorder symptom severity revealed no statistically significant differences between the two groups.
Analysis of electroencephalographic recordings uncovered additional localized neurophysiological differences between the two pediatric groups beyond the observed changes in alpha peak frequency. Compared against participants diagnosed with attention-deficit/hyperactivity disorder alone, children in the comorbid group demonstrated significantly reduced sensorimotor rhythm activity at the central electrode site. Furthermore, electrophysiological evaluations over the occipital region identified a significantly lower theta/beta ratio accompanied by heightened occipital beta frequency activity within the comorbid cohort.
The investigators emphasized the clinical context surrounding these distinctions, noting that attention-deficit/hyperactivity disorder frequently co-occurs with anxiety, creating complex diagnostic and therapeutic challenges in clinical settings. The authors also documented that stimulant medications routinely prescribed for the management of attention-deficit/hyperactivity disorder can exacerbate anxiety symptoms in certain pediatric patients, although this adverse reaction is not observed consistently across all individuals.
Despite the identified neurobehavioral differences between the clinical groups, the researchers cautioned that these electrophysiological variations require replication across independent cohorts. The authors explicitly concluded that the ultimate diagnostic utility and treatment-related relevance of alpha peak frequency, the theta/beta ratio, and the sensorimotor rhythm in this pediatric population remain to be established through future scientific investigation.
Subject of Research: Neurobehavioral and electrophysiological differences in children with ADHD and comorbid anxiety
Article Title: Neurobehavioral Assessment of ADHD and Anxiety Co-occurrence in Pediatric Populations
Article References: Sabaghypour, S., Farkhondeh Tale Navi, F., Radaee, M., Zadehahmad Sabzi, A., Masoudi, M., Davoodabadi, S., & Shakibaei, F. (2026). Neurobehavioral Assessment of ADHD and Anxiety Co-occurrence in Pediatric Populations. Child Psychiatry & Human Development. https://doi.org/10.1007/s10578-026-02125-0
Image Credits: AI Generated
DOI: 10.1007/s10578-026-02125-0
Keywords: attention-deficit/hyperactivity disorder, pediatric anxiety, alpha peak frequency, theta/beta ratio, sensorimotor rhythm, electroencephalography, Conners' Parent Rating Scale-Revised, Spence Children's Anxiety Scale, DSM-5 diagnostic criteria, central electrodes, occipital beta activity, frontal brain regions, stimulant medications, pediatric neurophysiology, comorbid anxiety, neurobehavioral assessment, occipital electrophysiology
News Source: Glenn Wilkins. (November 14, 2026). Children With ADHD and Anxiety Display Lower Alpha Peak Frequency in Study. Scienmag.



